Sally Allain
Head of Johnson & Johnson Innovation – JLABS @ Washington, DC

Having started her research career in biotech startups, Sally Allain has a deep understanding of the needs of healthcare entrepreneurs. That background has enriched her work at JLABS @ Washington, DC, J&J’s external R&D incubator throughout the greater metro region, where she sets the strategic direction and oversees all operational activities. In this role, she’s evaluated and selected a strong portfolio of innovators for her location and fostered strategic partnerships with corporate, academic, government and industry organizations in the region.


Hillary Bergman 
Account supervisor, Wunderman Thompson Health

Since joining Wunderman Thompson Health in 2018, Hillary Bergman has served as the day-to-day lead on multiple Pfizer businesses across internal medicine (Chantix), oncology (Xalkori, Lorbrena, Vizimpro), vaccines (Prevnar and Trumenba) and rare disease (launching a GTx for DMD). Her focus is mainly on the consumer side of the pediatrics business, where she feels she can have the greatest impact through helping patients and caregivers become their own advocates and making them aware of available life-saving treatments. 


Jessica Botting
Director, social media, Klick Health

The global upheavals of 2020 made it a tumultuous year for pharma social media marketers. But Jessica Botting went above and beyond to guide Klick and her clients through it. Botting’s consistent prioritization of education for internal and external stakeholders, such as new-to-social clients, review teams, science and regulatory, and creative, has helped the Klick team grow and drive success for the brand marketers that work with her. 


Alexandra Charles
VP, account group supervisor, The Lynx Group

Alexandra Charles has demonstrated her complete vision of how clients can most effectively reach oncology patients with two recent high-profile launches: the Pfizer Oncology Patient Navigation in Cancer Care 2.0 Toolkit and the launch of Mylan Canada’s Oncology Biosimilars Without Border unbranded disease state education, which was well-received by oncologists after its rollout across the major provinces. She has worked in a wide range of therapeutic areas including cardiology, oncology, CNS, women’s health and rare disease throughout all drug life cycles during her more than 15-year career.


Amber Chenevert
Group director, strategy and insights; Culture Studio lead, VMLY&R

With her mix of academic and agency experience, Amber Chenevert inspires clients to embrace new ways of reaching consumers. As the director of the LifeScan account — leading global brand strategy and research formalizing data mining capabilities for their OneTouch portfolio of products and partner brands — she helped grow the business from $1 million to $10 million. As director of the Culture Studio at VMLY&R, she helps brands uncover new market opportunities, while supporting inclusion by expanding and integrating capabilities that give marginalized groups greater access to the industry.


Lindsay Danylak
VP, Spectrum Science

In 2020, Lindsay Danylak led AstraZeneca spinoff Viela Bio through the company’s first product approval and launch. She also helped the team pivot during the pandemic, moving to virtual ad boards and adapting communications plans and materials to address the growing concerns of neurologists and patients surrounding COVID-19, among other initiatives. And, in just under three years, she’s brought in more than $7 million in new business and organic growth.


Genevieve Desmond
Director of brand experience and product marketing, Akili Interactive

Genevieve Desmond’s strategic mind and ability to execute were on full display last spring when the FDA released special COVID-19 guidance allowing treatments that hadn’t received FDA clearance to be made available without prescription. As Akili jumped to make EndeavorRx available to patients in need, Desmond helped soft-launch the product in just five days, taking the lead in mapping out caregiver and patient journeys, creating email communications for engaging caregivers throughout and writing materials for the Akili Assist patient support group.


Michelle Edwards
ViP, human resources and operations, Heartbeat

During her 11-year tenure in human resources at Heartbeat, Michelle Edwards has created a culture that earned four straight “Best Places to Work” awards from AdAge. Equitable career development is a major focus for Edwards. In 2020, the agency’s VP and above promotions reflected a strong commitment to diversifying senior ranks, with 43% going to women of color and 71% going to women overall.  


Erin Fitzgerald
VP, group director, account management, Digitas Health

Erin Fitzgerald oversees the women’s cancer franchise at Digitas Health, and in the last three years has grown the practice from less than $1 million to $3.5 million in revenue annually. She’s worked on some of the largest oncology brands in the industry and is currently part of the account leadership for Merck’s Keytruda business. She simultaneously launched the disease state education breast cancer campaign and two back-to-back indications in triple negative breast cancer (TNBC), which disproportionately affects Black and Hispanic/Latino individuals.


Katrina Sergeev Gary 
Director of patient marketing and engagement, Argenx

In her two years at Argenx, Katrina Sergeev Gary has led several innovative and successful campaigns focused on the myasthenia gravis (MG) community. Her work includes the launch of the digital platform MG United; My MG Sole, a storytelling project that used the tenets of art therapy to inspire the MG community to connect virtually; and A Mystery to Me, the first-ever documentary film series about myasthenia gravis, which was honored with a selection in the 2020 Chicago International Film Festival and was nominated for a 2021 MM+M Brand Film Award.


Abby Hayes
Practice leader, DE&I engagement, Real Chemistry

As COVID-19 exacerbated existing racial inequities and the murder of George Floyd and killing of Breonna Taylor spurred a national movement, Abby Hayes led the response of Real Chemistry and many of its large clients as the head of the firm’s diversity, equity and inclusion engagement practice. She provided real-time crisis counseling for more than 15 clients, all of whom took action, including a $100 million commitment by one large client to promote health equity in the U.S. Under her leadership, DE&I client programming is tracking to grow by 300%-400% in 2021.


Dr. Alison Leaf 
Senior program manager, Seven Bridges

Since joining Seven Bridges in 2017, Dr. Alison Leaf has developed and executed a winning proposal to the NIH Data Commons Pilot and led a program with the National Heart, Lung and Blood Institutes’ BioData Catalyst project that provides researchers with a cloud-based ecosystem to explore and analyze high-value genomics datasets. The COVID-19 pandemic has only underscored the importance of this system, as the comparative analysis of host genomics, medical imaging and health outcomes will be critical in managing the long-term health of millions of affected patients.


Elizabeth McShea
Director, social media, CMI Media Group

During her three-year tenure at CMI Media Group, Elizabeth McShea has excelled in demonstrating the value of a best-in-class social listening and research arm. Her work has led clients to invest in social research programs, advancing the team from 16 deliverables in 2018 to 121 and growing in 2020. She’s also the go-to on the social team for new business pitches and opportunities. Known as one of the best presenters at the agency, she has led more than 10 pitches since joining the firm.


Lauren Murphy
Director, consumer marketing, Biohaven Pharmaceuticals

Not long after Lauren Murphy joined Biohaven, she was challenged with leading communications, consumer marketing and patient engagement for the company’s first commercial product launch in the middle of the COVID-19 pandemic. She successfully headed up the first-to-market and fastest in pharma DTC launch for Nurtec ODT, which included first-in-pharma activations with digital partners including Google and Twitter, meeting patients where they are. Throughout the pandemic, she has continued to gracefully lead the development and execution of brand DTC, celebrity partnership activations and more. 


Katie Ramirez
VP, digital, GCI Health

With her hybrid skill set in client service and technical acumen, Katie Ramirez has made herself an indispensable part of the GCI Health team, counseling some of the agency’s most important clients on digital and social strategy. Currently, she leads digital and social media strategy for the award-winning Bristol Myers Squibb (BMS) cancer advocacy initiative Survivorship Today, which offers cancer survivors resources for life after active treatment. Under her leadership, the campaign’s social posts have passed industry benchmarks on all measures.


Kristi Reeves-Pennington
Trelegy consumer marketing director, COPD and asthma, GSK

Throughout her 20-year career, Kristi Reeves-Pennington has excelled at building brands through empathy and deeper understanding. Working in the COPD and asthma area of GSK’s Respiratory Division, she led a shift in the marketing strategy for Trelegy based on insight-backed authenticity, which resonated strongly with patients who often felt misrepresented. This was demonstrated in the launch of Trelegy’s New Day campaign in November 2020, which led to significant increases in organic and paid search.


Kara Reheis
VP, marketing, Daiichi Sankyo

Kara Reheis has been at the forefront of several monumental shifts at Daiichi Sankyo, including as one of the primary commercial leads in finalizing a multibillion-dollar co-commercialization agreement with a major pharmaceutical collaborator. Most recently, her 42-person commercial training and development team earned the Life Sciences Trainers and Educators Network Excellence Award for its training curriculum in support of the launch of a metastatic breast cancer therapy. 


Nikki Sidi 
VP, global strategic marketing, surgical, Johnson & Johnson Vision 

As the leader in worldwide marketing strategy for J&J’s ophthalmology portfolio, Nikki Sidi heads a global team that drives business and pipeline strategy, as well as new product introductions. She has reorganized the global marketing function and, last year, achieved intraocular lens (IOL) share gains in every region. In 2021, she and her team are preparing the first-ever global campaign to celebrate the 20th anniversary of J&J’s vision legacy TECNIS platform, relaunching the TECNIS masterbrand and introducing a series of new products that will broaden J&J’s IOL portfolio. 


Takae Takahashi
SVP, associate creative director, Havas Health & You/Havas Health Plus

With a background in illustration and graphic design, Takae Takahashi has applied her creativity to the world of pharma with impressive results. Her array of awards includes five Clios and four Cannes Lions, and she was the first winner of the Innovation Health Hackathon at Cannes for her Parkinsounds Project for Teva Pharmaceuticals, which leveraged the power of music to treat Parkinson’s patients. At Havas, her outside-the-box thinking has increased revenue and profit by more than 30% and brand awareness by more than 40%.